Leap Therapeutics Inc LPTX:NASDAQ

Last Price$1.23NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change-0.09(6.82%)
Bid (Size)$1.23 (1)
Ask (Size)$1.41 (10)
Day Low / High$1.18 - 1.35
Volume804.4 K

Leap Therapeutics, Leica Team Up to Develop Companion Diagnostic for Cancer Patients

7:51AM ET 1/31/2022 MT Newswires
Leap Therapeutics (LPTX) said Monday that it has teamed up with Leica Biosystems to develop a companion diagnostic to detect Dickkopf-related protein 1.

The company plans to use the assay to support the clinical development of its anti-DKK1 cancer therapy, called DKN-01. DKN-01 is currently being examined in clinical trials.

DKK1 is a protein often shown in cancer that allows tumor cells to suppress the body's immune system, leading to unregulated growth.

Leica Biosystems is a cancer diagnostics company.

Leap shares rose 2.3% in premarket trading.

Price: 1.75, Change: +0.04, Percent Change: +2.34